9th Annual Meeting of the American Delirium Society
Boston Park Plaza Hotel, Boston, MA
The 2019 ADS Annual Meeting Conference Planning Committee is now accepting abstracts for presentation at our 9th Annual Meeting that will be held June 16-18, 2019 at the Boston Park Plaza Hotel in Boston, MA.
Abstracts will be accepted until January 21, 2019 23:59h (PST)
We welcome abstracts from clinicians/researchers/administrators from around the world that pertain to delirium research, practice, quality improvement and/or education.
Abstracts presented at other professional meetings are welcome as long as the abstract results have not been published in the peer-review literature at the time of abstract submission.
To submit your abstract please follow the directions at the bottom.
The meeting program and details regarding registration/travel will be forthcoming.
Please note that abstracts making no mention of delirium or missing results will not be considered.
Each abstract proposal should contain a title of no more than 28 words and a brief structured abstract of no more than 300 words. Abstracts are limited to a maximum of 8 authors. Please use only generic medication names and define all abbreviations with first usage. When percentages are used, the absolute numbers from which the fractions are derived must also be stated.
Please organize abstract sections using the following headings:
OBJECTIVE(s) – The hypothesis tested or purpose of the study.
METHODS – Details of the study design/protocol
RESULTS – Results of the study with appropriate statistical inferences
CONCLUSIONS – Clinical importance and potential significance of findings
Because the review process is blinded, neither the title nor text of the abstract should contain authors’ names, affiliations, or other personal identifying information. Any references to the authors' own work should be made in the third person.
All authors must approve each abstract prior to submission.
Two educational objectives must be provided at the time each abstract is submitted.
You will be asked to confirm whether you are (or are not) a NIDUS investigator/bootcamp graduate during the abstract submission process.
Unless it is noted at the time of abstract submission that a poster presentation only is preferred, authors of top-scoring abstracts will be invited to present their research as an oral presentation on either Monday, June 17 or Tuesday, June 18, 2019. All other accepted abstracts will be invited to deliver a poster presentation during the late afternoon poster reception on Monday, June 17, 2019. Oral abstract presenters will be given a maximum of 10 minutes to present their work followed by 5 minute question and answer period.
Abstracts are selected by a blinded panel of at least 3 expert reviewers based on the following criteria: 1. Originality; 2. Quality; 3. Clarity of message; and 4. Significance of results.
Notification of acceptance will be sent to all abstract authors no later than March 1, 2019.
Please reach out to the American Delirium Society email@example.com with any questions or concerns.
Thank you for submitting your research to the American Delirium Society!
John Devlin, PharmD, Co-Chair
Babar Khan, MD, Co-Chair
Conference Programming Committee, ADS Boston 2019
If you have any technical issues, please click on “Site Support,” at the bottom of the login page. For additional help, please use this helpful guide.